HR 5629 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect.
To provide that the final rule of the Department of Health and Human Services titled ``Medications for the Treatment of Opioid Use Disorder'', except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect.
Summary
- Repeals the Department of Health and Human Services final rule titled "Medications for the Treatment of Opioid Use Disorder" published on February 2, 2024.
- Specifies that the repealed rule shall have no force or effect, meaning it no longer applies.
- Preserves the portion of the rule relating to accreditation of opioid treatment programs under 42 CFR part 8, subpart B, which continues to be in effect.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
-
![Rep. Houchin, Erin [R-IN-9]](https://media.civicgate.org/people/d/politicians/H001093.thumb.jpg)
Rep. Houchin, Erin (R-IN) [#9]
Money behind the sponsor
Top reported contributors to Erin Houchin’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
- Employer not reported $21,100
- KIESLER POLICE SUPPLY, INC. $13,700
- ELWOOD STAFFING $12,400
- ANDREESSEN HOROWITZ $12,399
- APOLLO $9,100
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Erin Houchin → · Outside spending →
Actions (2)
- Sep 30, 2025 Referred to the House Committee on Energy and Commerce. · house
- Sep 30, 2025 Introduced in House
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Text versions (1)
Bills are re-published as they move (Introduced → Reported → Engrossed → Enrolled …). Each stage below is a separate text; pick two to see what changed. Data from Congress.gov.
Committee action
What happened to this bill in committee — the meetings where it was considered and every recorded vote taken on it.
Meetings where this bill was on the agenda
Full text
IN THE HOUSE OF REPRESENTATIVES
September 30, 2025
Mrs. Houchin introduced the following bill; which was referred to the Committee on Energy and Commerce
A BILL
To provide that the final rule of the Department of Health and Human Services titled “Medications for the Treatment of Opioid Use Disorder”, except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. RULE RELATING TO MEDICATIONS FOR THE TREATMENT OF OPIOID USE DISORDER.
(a) In General.—Except as provided by subsection (b), the final rule of the Department of Health and Human Services titled “Medications for the Treatment of Opioid Use Disorder” (89 Fed. Reg. 7549; published February 2, 2024) shall have no force or effect.
(b) Exception.—Subsection (a) shall not apply to the portion of the final rule that makes modifications to subpart B of part 8 of title 42, Code of Federal Regulations (relating to accreditation of opioid treatment programs). <all>
Comments